Radius Health Announces Third Quarter 2019 Results and Corporate Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Radius Health (RDUS) Tops Q3 EPS by 38c; Raises FY19 Sales Outlook
November 5, 2019 4:25 PM ESTRadius Health (NASDAQ: RDUS) reported Q3 EPS of ($0.44), $0.38 better than the analyst estimate of ($0.82). Revenue for the quarter came in at $46.77 million versus the consensus estimate of $45.69 million.
I am very pleased with our continued strong performance with TYMLOS. We are on a path to make TYMLOS the treatment of choice for high... More
